Ticker Details
ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date:	December 14, 2012
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$441.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.21 | 1.14%
Avg Daily Range (30 D):	$3.94 | 1.71%
Avg Daily Range (90 D):	$3.08 | 1.40%

Institutional Daily Volume
Avg Daily Volume:	6.1M
Avg Daily Volume (30 D):	5.16M
Avg Daily Volume (90 D):	4.84M

Trade Size
Avg Trade Size (Sh.):	101
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	65,414
Avg Institutional Trade:	$11.09M
Avg Institutional Trade (30 D):	$44.34M
Avg Institutional Trade (90 D):	$35.15M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	19

Market Closing Trades
Avg Closing Trade:	$96.22M
Avg Closing Trade (30 D):	$452.6M
Avg Closing Trade (90 D):	$349.62M
Avg Closing Volume:	798.59K

News

Jul 9, 2026 @ 12:15 PM Vanguard Health Care vs. VanEck Pharmaceutical: Ho... Source: Erin Kennedy

Jul 9, 2026 @ 11:34 AM ProShares vs. iShares: Is NOBL or HDV the Better D... Source: Josh Kohn-Lindquist

Jul 9, 2026 @ 6:56 AM Internationales Beratergremium für Handel und I... Source: Ccpit Shandong Sub-Council

Jul 9, 2026 @ 6:56 AM Si è tenuta a Jinan la tavola rotonda 2026 dei ... Source: Ccpit Shandong Sub-Council

Jul 8, 2026 @ 10:04 PM Invesco Pharmaceuticals ETF or First Trust Biotech... Source: Brendan Coffey

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$2.03	$.39	$1.02
Diluted EPS	$2.03	$.39	$1.02
Revenue	$62.82B	$15B	$16.62B
Gross Profit	$44.4B	$10.78B	$12.07B
Net Income / Loss	$3.64B	$697M	$1.82B
Operating Income / Loss	$15.33B	$3.99B	$4.54B
Cost of Revenue	$18.42B	$4.22B	$4.55B
Net Cash Flow	$4.22B	$4.16B	$-400M
PE Ratio